Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference

Back to Jobs

SAN DIEGO , Nov. 15, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David A. Weber , Ph.D., president and chief executive officer, will participate in a fireside chat at

Apply Now